Table 1.
Demographics, laboratory and lung function tests comparison between the sarcoidosis and control groups.
| Sarcoidosis n = 10 |
HP n = 7 |
Control n = 9 |
P | |
|---|---|---|---|---|
| Age (yr) | 39 (27-65) | 42 (28-61) | 0.48 | |
| ACE (U/l) | 61 | 76 | 23 | 0.0004 |
| Macrophages BAL/induced sputum (%) | 63/36.9 | 34/23.7 | 81/45 | 0.0032/0.045 |
| Lymphocytes BAL/induced sputum (%) | 34/5.2 | 57/8.1 | 14/2.4 | 0.0002/0.0002 |
| Neutrophils BAL/induced sputum (%) | 1/54 | 1/63.7 | 1/51 | 0.00005/0.67 |
| Eosynophiles BAL/induced sputum (%) | 1/0 | 1/1 | 1/1 | NS/NS |
| CD4 BAL/induced sputum (%) | 59/32 | 20/27 | 36/24 | 0.00001/0.032 |
| CD8 BAL/induced sputum (%) | 20/14 | 5/21 | 17/11 | 0.350/0.46 |
| CD4/CD8 ratio BAL/induced sputum | 2.8/5.0 | 0.04/1.2 | 1.9/1.3 | 0.0002/0.0045 |
| CD4/25 high/127 low BAL/induced sputum | 2.3/38.3 | 9.5/7.1 | 2.1/5.3 | 0.7; 0.006/0.0034; 0.0043 |
| Ca plasma mmol/l | 2.4 | 2.2 | 2.3 | 0.7 |
| Ca 24-h urine mmol/l | 6.1 | 6.4 | 5.7 | 0.21 |
Values are median (range); NS-non specific.